Thoroughbred Financial Services LLC purchased a new stake in shares of Centene Corporation (NYSE:CNC – Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 11,273 shares of the company’s stock, valued at approximately $700,000.
A number of other hedge funds have also modified their holdings of CNC. BlackRock Inc. purchased a new stake in shares of Centene during the second quarter worth $2,660,422,000. Wellington Management Group LLP boosted its position in Centene by 423.0% during the second quarter. Wellington Management Group LLP now owns 13,301,215 shares of the company’s stock valued at $853,805,000 after purchasing an additional 10,757,914 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Centene by 12.4% in the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,517,580 shares of the company’s stock valued at $354,173,000 after purchasing an additional 608,249 shares in the last quarter. Assenagon Asset Management S.A. grew its stake in Centene by 21.6% in the third quarter. Assenagon Asset Management S.A. now owns 4,518,785 shares of the company’s stock valued at $302,818,000 after purchasing an additional 802,756 shares in the last quarter. Finally, Bank of America Corp DE acquired a new position in Centene in the 2nd quarter worth about $285,713,000. 93.63% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling at Centene
In other news, General Counsel Christopher Koster sold 56,500 shares of the business’s stock in a transaction on Wednesday, August 26th. The shares were sold at an average price of $66.90, for a total value of $3,779,850.00. Following the completion of the sale, the general counsel directly owned 248,854 shares in the company, valued at approximately $16,648,332.60. The trade was a 18.50% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.37% of the company’s stock.
Centene Trading Down 3.0%
Centene (NYSE:CNC – Get Free Report) last posted its earnings results on Tuesday, October 27th. The company reported $0.58 EPS for the quarter, topping the consensus estimate of $0.10 by $0.48. Centene had a net margin of 0.72% and a return on equity of 12.15%. The firm had revenue of $50.65 billion for the quarter, compared to the consensus estimate of $47.12 billion. During the same period in the prior year, the business posted $0.50 earnings per share. The business’s quarterly revenue was up 1.9% on a year-over-year basis. Analysts expect that Centene Corporation will post 5.27 EPS for the current fiscal year.
Analyst Ratings Changes
A number of research firms have recently weighed in on CNC. HC Wainwright reaffirmed a “buy” rating on shares of Centene in a research note on Friday, September 11th. UBS Group boosted their price target on Centene from $70.00 to $78.00 and gave the company a “neutral” rating in a research note on Wednesday, October 28th. Bank of America restated a “buy” rating and issued a $82.00 price objective (up from $80.00) on shares of Centene in a report on Wednesday, October 28th. Morgan Stanley set a $71.00 price objective on shares of Centene and gave the company an “equal weight” rating in a research report on Wednesday, October 28th. Finally, Stifel Nicolaus set a $79.00 price objective on shares of Centene in a research report on Monday, August 3rd. Nine analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Centene currently has a consensus rating of “Hold” and a consensus price target of $75.10.
View Our Latest Analysis on Centene
About Centene
Centene Corporation is a U.S. health care company that provides managed care and related services, primarily for people enrolled in government-sponsored health programs. Its offerings include Medicaid and Medicare plans, as well as health insurance sold through the Affordable Care Act marketplace. Centene serves members through health plans and a network of health care providers. Its businesses include Ambetter, which offers marketplace health plans, and Wellcare, which provides Medicare-related coverage.
Further Reading
- Five stocks we like better than Centene
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
